TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
99,07 R$
arrow_upward
+1,33%(+1,30) 1D
28 სექ, 20:23:55 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TAKP34...
Mkt. cap
58,34 მლრდ.
Avg. vol.
36,00
Volume
0,00
52-wk high
99,07 R$
52-wk low
70,80 R$
Shares outstanding
1,60 მლრდ.
No. of employees
47 ათ.
Mkt. cap
58,34 მლრდ.
Avg. vol.
36,00
Volume
0,00
52-wk high
99,07 R$
52-wk low
70,80 R$
Shares outstanding
1,60 მლრდ.
No. of employees
47 ათ.
News stories
From web sources and news partners
Stock Traders Daily
·
11 საათის წინ
(TAK) Movement Within Algorithmic Entry Frameworks
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd BDR
CEOკრისტოფ ვებერი | კრისტოფ ვებერი
Employees47 ათ.
Founded12 ივნ. 1781
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com